Latest News
Cereno Scientific publishes first peer-reviewed data on CS014, highlighting antithrombotic efficacy without bleeding risk
14 January 2026 - Biotechnology company Cereno Scientific (Nasdaq First North: CRNO B) on Wednesday reported publication of the first peer-reviewed manuscript on its HDAC inhibitor CS014 in the Journal of Thrombosis and Haemostasis, disclosing molecu...
EspeRare and n-Lorem partner to expand European access to ASO therapies for rare genetic diseases
14 January 2026 - Non-profit organisations the EspeRare Foundation, based in Switzerland, and US-based n-Lorem Foundation on Wednesday announced a strategic collaboration to expand access in Europe to n-Lorem's antisense oligonucleotide (ASO) th...
Bionpharma and STEERLife's Etravirine tablets approved by US FDA
14 January 2026 - STEERLife, the life sciences division of India-based STEER World, and Bionpharma Inc, a US-based pharmaceutical company, announced on Tuesday that Bionpharma has received Abbreviated New Drug Application (ANDA) approval from the US ...
Rakuten Medical signs manufacturing agreement with LOTTE Biologics
14 January 2026 - Biotechnology company Rakuten Medical Inc announced on Wednesday that it has signed a biopharmaceutical contract manufacturing agreement with LOTTE Biologics, a South Korea-based company that operates integrated biologics facilities...
ElpasBio partners with Fosun Kairos on AlloJoin stem cell therapy
14 January 2026 - Clinical-stage biotechnology company ElpasBio Holdings announced on Tuesday that it has entered into a collaboration agreement with Fosun Kairos, the core cell therapy platform of China-based Fosun Pharma (SSE:600196; HKEX:2196).Thi...